NDTV, India home to worlds secondlargest diabetes population in 2024: Study , NDTV Health For 250 million obese Indians, the weight is finally over , The Times (UK) Reuters, Novo Nordisk patent expiry opens door to cheaper weightloss drugs in India , 19 March 2026 BBC News, Weightloss drug prices expected to fall sharply following patent expiry , 18 March 2026 Pharmacy.biz, Semaglutide patent expiry in India paves the way for generics PharmaLive, Semaglutide patent cliff presents substantial opportunity for generics markets
Wegovy pill approved in the US as first oral GLP-1 for weight management
Usage Frequency Begin gradually and monitor skin comfort
Lower concentrations (0.51%) are used for general scalp health and maintenance
The 100% natural formulation provides a sense of security for users looking for safe and effective ways to support their health